Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-10-03
2010-10-26
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S184000
Reexamination Certificate
active
07820662
ABSTRACT:
Compounds of the formulaand pharmaceutically acceptable salts thereof, wherein X1, X2, X3, X4, X5, X6, X7, R1, and Q1are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of hyperproliferative diseases such as cancer, inflammation, psoriasis, allergy/asthma, disease and conditions of the immune system, disease and conditions of the central nervous system.
REFERENCES:
patent: 5217999 (1993-06-01), Levitzki
patent: 5302606 (1994-04-01), Spada
patent: 5397787 (1995-03-01), Buzzetti
patent: 5556874 (1996-09-01), Dobrusin
patent: 6194439 (2001-02-01), Dow
patent: 6265411 (2001-07-01), Thomas
patent: 6337338 (2002-01-01), Kozlowski
patent: 6362336 (2002-03-01), Lohmann
patent: 6486179 (2002-11-01), Jirousek
patent: 6939874 (2005-09-01), Harmange
patent: 7087602 (2006-08-01), Thomas
patent: 7087613 (2006-08-01), Norris
patent: 7115617 (2006-10-01), Buchanan
patent: 7202243 (2007-04-01), Hendrix
patent: 7244733 (2007-07-01), Hunt
patent: 7271262 (2007-09-01), La Greca
patent: 7326699 (2008-02-01), Capraro
patent: 7332497 (2008-02-01), Hirst
patent: 7345038 (2008-03-01), Bright
patent: 2002/0076408 (2002-06-01), Buchsbaum
patent: 2003/0108545 (2003-06-01), Rockwell
patent: 2003/0114467 (2003-06-01), Shakespeare
patent: 2003/0144252 (2003-07-01), Furr
patent: 2003/0153752 (2003-08-01), Hirst
patent: 2003/0157104 (2003-08-01), Waksal
patent: 2003/0175763 (2003-09-01), Degenhardt
patent: 2004/0014774 (2004-01-01), Myers
patent: 2004/0052785 (2004-03-01), Goodman
patent: 2004/0057950 (2004-03-01), Waksal
patent: 2004/0092546 (2004-05-01), Wei
patent: 2004/0102655 (2004-05-01), Liang et al.
patent: 2004/0106605 (2004-06-01), Carboni
patent: 2004/0180911 (2004-09-01), Capraro
patent: 2004/0220189 (2004-11-01), Sun
patent: 2005/0032759 (2005-02-01), Massimini
patent: 2005/0037999 (2005-02-01), La Greca
patent: 2005/0054638 (2005-03-01), Barlaam
patent: 2005/0136063 (2005-06-01), Wang
patent: 2005/0153966 (2005-07-01), Gangloff
patent: 2005/0215530 (2005-09-01), Ryan
patent: 2005/0215564 (2005-09-01), Stiles
patent: 2005/0271747 (2005-12-01), Higgins
patent: 2006/0019957 (2006-01-01), Crew
patent: 2006/0046977 (2006-03-01), Nunes
patent: 2006/0069084 (2006-03-01), Burns
patent: 2006/0084654 (2006-04-01), Beck
patent: 2006/0154982 (2006-07-01), Larsson
patent: 2006/0166992 (2006-07-01), Hendrix
patent: 2006/0235031 (2006-10-01), Arnold
patent: 2007/0087613 (2007-04-01), Schumacher
patent: 2007/0112005 (2007-05-01), Chen
patent: 2007/0149521 (2007-06-01), Crew
patent: 2007/0202101 (2007-08-01), Rosen
patent: 2007/0238734 (2007-10-01), Nemecek
patent: 2007/0280928 (2007-12-01), Buck
patent: 2008/0014200 (2008-01-01), Arnold
patent: 2008/0139582 (2008-06-01), Honigberg
patent: 2008/0254040 (2008-10-01), Stefanic
patent: 2008/0267957 (2008-10-01), Arnold
patent: 97/28161 (1997-08-01), None
patent: 00/17203 (2000-03-01), None
patent: 01/12227 (2001-02-01), None
patent: 01/72751 (2001-10-01), None
patent: 0172751 (2001-10-01), None
patent: 02/060492 (2002-08-01), None
patent: 02/079192 (2002-10-01), None
patent: 02/092599 (2002-11-01), None
patent: 03/000187 (2003-01-01), None
patent: 03/024967 (2003-03-01), None
patent: 03/080064 (2003-10-01), None
patent: 03080064 (2003-10-01), None
patent: 2004/056830 (2004-07-01), None
patent: 2005/037836 (2005-04-01), None
patent: 2005/061519 (2005-07-01), None
patent: 2005/097800 (2005-10-01), None
patent: 2006004703 (2006-01-01), None
patent: 2007/075554 (2007-07-01), None
patent: 2007079164 (2007-07-01), None
patent: 2008/076143 (2008-06-01), None
patent: 2008/106168 (2008-09-01), None
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface.
Akio et al (1995) , Abstract of JP 07133280.
Akio, et al. (1995) Machine English Translation of JP 071333280.
Adachi, et al. (2004) CAS Accession #2005:366557, corresponding to Novartis Foundation Symposium 262 (biology of IGF-1), 177-192.
Albert, A. et al. (1970) Journal of the Chemical Society, vol. 11, pp. 1540-1547 *.
Albert, A. et al. (1969) Chem. Biol. Pterdines.Proc.Int.Symp., 4th, 4:1-5 *.
Arteaga, C.L. and Johnson, D.H. (2001) Current Opinion Oncol. 13:491-498.
Baserga R. (1999) Exp.Cell.Res, vol. 253, pp. 1-6 *.
“Bevacizumab and Gemcitabine Combined with either Cetuximab or Erlotinib in Treating Patients with Advanced Pancreatic Cancer” “Internet Citation, [Online] Sep. 7, 2004, XP002410261. Retrieved from the Internet: URL: http://www.clinicaltrials.gov/ct/gui/show/NCT00091026> [retrieved on Dec. 1, 2006] the whole document.”.
Bulgaru, A.M. et al. (2003) Expert Rev. Anticancer Ther.3:269-279.
Ciardiello, F. et al. (2000) Clin. Cancer Res. 6:2053-2063.
Ciardiello, F. et al. (2000) Clin. Cancer Res. 6:3739-3747.
Ciardiello, F. et al. (2003) Clin. Cancer Res. 9:1546-1556.
Contessa, J. N. et al. (1999) Clin. Cancer Res. 5:405-411.
Dancey, J. and Sausville, E.A. (2003) Nature Rev. Drug Discovery 2:296-313.
de Bono, J.S. and Rowinsky, E.K. (2002) Trends in Mol. Medicine 8:S19-S26.
Grunwald, V. and Hidalgo, M. (2003) J. Nat. Cancer Inst. 95:851-867.
Gupta, R.A. and DuBois, R.N. (2000) Nature Med. 6:974-975.
Gura, et al. (1997) Science 278:1041-1042.
Hartz, R.A. et al (2002) Bioorganic & Medicinal Chemistry Letters, vol. 12, pp. 291-294 *.
Herbst, R.S. et al. (2001) Expert Opin. Biol. Ther. 1:719-732.
Holbro, T. and Hynes, N. E. (2004) Annu Rev Pharmacol Toxicol 44:195-217.
Huang, S. et al. (1999) Cancer Res. 59:1935-1940.
Hurbin, A. et al. (2003) Ann. N. Y. Acad. Sci 1010:354-357.
Johnson, et al. (2001) British Journal of Cancer 84:1424-1431.
Jones, H.E. et al. (2004) Endocr Relat Cancer 11:793-814.
Khalil, M.Y. et al. (2003) Expert Rev. Anticancer Ther. 3:367-380.
Kim, E.S. et al. (2001) Current Opinion Oncol. 13:506-513.
Knowlden, J. M. (2005) Endocrinology 146(11):4609-4618.
Krishnan, S. et al. (2003) Frontiers in Bioscience 8, e1-13.
Kurmasheva, R. T. and Houghton, P. J. (2006) Biochim Biophys Acta 1766:1-22.
Levitzki, A. (2003) Lung Cancer 41 Suppl 1, S9-14.
Li, M. et al. (2002) Clin.Cancer Res. 8:3570-3578.
Liu, B. (2001) Oncogene 20:1913-1922.
Lu, Y. at al. (2001) Journal of the National Cancer Institute 93: 1852-1857.
Magne, N. et al. (2002) British Journal of Cancer 86:819-827.
Magne, N. et al. (2003) Clin. Can. Res. 9:4735:4732.
Morgillo, F. et al. (2006) Cancer Res 66(20):10100-10111.
Nahta, R. (2005) Cancer Research 65:11118-111128.
National Library of Medicine—Medical Subject Headings definition of Sarcoma (http://www.nlm.nih.gov/mesh/2008/MBrowser.html, then type “sarcoma”); last accessed Jul. 1, 2008. *
Parrizas et al (1997) Endocrinology, vol. 138, pp. 1427-1433 *.
Raben, D. et al. (2002) Semin. Oncol. vol. 29, No. 1, suppl 4 (February): 37-46.
Roskoski, R., Jr. (2004) Biochem Biophys Res Commun 319:1-11.
Seymour, L. (2003) Current Opin. Investig. Drugs 4(6):658-666.
Solomon, B. et al (2003) Int. J. Radiat. Oncol. Biol. Phys. 55:713-723.
Stein, J.H. et al (1994) Internal Medicine 4th Edition, Chapters 71 and 72, pp. 699-729 *.
Thomas, et al. (1998) Expert Opinion Ther. Pat., vol. 8, pp. 475-478 *.
Torrance, C.J. et al. (2000) Nature Med. 6:1024-1028.
Tortora, et al. (2003) Clin. Cancer Res. 9:1566-1572.
Valeriote, et al. (1975) Cancer Chemotherapy Reports (5):895-900.
Austrian Search Report and Written Opinion in Singapore 200606863-9 on Dec. 23, 2008.
International Search Report in PCT/US2004/034219—May 6, 2005.
International Preliminary Report on Patentability in PCT/US2004/034219—May 6, 2005.
Written Opinion of the International Search Authority in PCT/US2005/010606—Aug. 19, 2005 *.
International Preliminary Report on Patentability in PCT/US2005/010606—Jul. 6, 2006 *.
International Search Report and Written Opinion of the International Search Authority in PCT/US2006048222—Jul. 4, 2007.
International Search Report and Written Opinion of the International Search Authority in PCT/US2007/009178—Apr. 21, 2008.
International Search Report and Written Opinion of the International Search Authority in PCT/US2008/002593—A
Arnold Lee D.
Cesario Cara
Coate Heather
Crew Andrew Philip
Dong Hanqing
Murray Jeffrey H
OSI Pharmaceuticals, Inc.
Wilson James O
LandOfFree
6,6-bicyclic ring substituted heterobicyclic protein kinase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6,6-bicyclic ring substituted heterobicyclic protein kinase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6,6-bicyclic ring substituted heterobicyclic protein kinase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4210629